It is now widely understood that cancer is a disease of acquired defects in genes and gene function. An article published Feb. 9 in Science, and authored by Andrew Feinberg, M.D., of the Johns Hopkins Kimmel Cancer Center ...
Feb 10, 2023
0
51
Scientists investigating the causes of lymphoedema have made a major discovery, revealing that lymphatic vessels can produce red and white blood cells.
Feb 6, 2023
0
52
Primary lung neuroendocrine tumors are very rare tumors that represent about 1-2% of all lung cancer cases. Only 2,000 to 4,500 are diagnosed in the U.S. each year. The common treatment for early stage lung neuroendocrine ...
Feb 3, 2023
0
6
Researchers at the University of Sussex are using Artificial Intelligence (AI) technology to analyze different types of cancer cells to understand different gene dependencies, and to identify genes that are critical to a ...
Feb 3, 2023
0
12
Researchers at the Hong Kong University of Science and Technology (HKUST) developed a novel technology which allows genomic DNA and RNA sequencing to be carried out simultaneously in single cells of both frozen and fresh ...
Feb 2, 2023
0
22
New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.
Feb 2, 2023
0
2
A research team led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering at KAIST succeeded in using systems biology research to change the properties of carcinogenic cells in the lungs and eliminate ...
Jan 30, 2023
0
21
The first comprehensive study of somatic mutations in normal human small intestine has been conducted by researchers at the Wellcome Sanger Institute and their collaborators. The findings revealed that an enzyme named APOBEC1 ...
Jan 27, 2023
0
21
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a new drug target for Ewing sarcoma, a rare kind of cancer usually diagnosed in children and young adults. Their experiments show that the cells causing this ...
Jan 19, 2023
0
83
Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that may offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain ...
Jan 16, 2023
0
29
